- Report
- November 2023
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- May 2024
- 196 Pages
Global
From €5237EUR$5,450USD£4,503GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,189GBP
Rimantadine is an antiviral drug used to treat and prevent influenza A, a type of infectious disease. It is an adamantane derivative, and works by blocking the M2 protein, which is an ion channel that helps the virus to enter the host cell. It is available in both oral and intravenous forms, and is used to treat mild to moderate cases of influenza A. It is also used to prevent the spread of the virus in high-risk populations, such as the elderly and those with weakened immune systems.
Rimantadine is generally well-tolerated, with few side effects. However, it is not effective against influenza B, and is not recommended for use in children under the age of two.
The rimantadine market is a small but important part of the infectious diseases drugs market. It is used to treat and prevent influenza A, and is an important tool in the fight against the spread of the virus.
Some companies in the rimantadine market include GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more